Search

Your search keyword '"Kawahito Y"' showing total 367 results

Search Constraints

Start Over You searched for: Author "Kawahito Y" Remove constraint Author: "Kawahito Y"
367 results on '"Kawahito Y"'

Search Results

1. New type of half-metallic fully compensated ferrimagnet

3. POS0151 SINGLE-CELL RNA SEQUENCING OF BRONCHOALVEOLAR LAVAGE FLUID AND BLOOD REVEALS DISEASE-SPECIFIC CHARACTERISTICS OF IMMUNE CELLS IN CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE PATIENTS

4. AB0786 INDUCTION THERAPY WITH RITUXIMAB ENABLES SUSTAINED REMISSION IN ELDERLY PATIENTS WITH RELAPSED ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE ANALYSIS FROM J-CANVAS, A JAPANESE MULTICENTRE-COHORT

9. POS0247 GLUCOCORTICOID TAPERING STRATEGY FOR ANCA-ASSOCIATED VASCULITIS: ADDRESSING THE GAP BETWEEN RECOMMENDATIONS AND REAL-WORLD PRACTICE

11. POS0822 HYPERTROPHIC PACHYMENINGITIS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A MULTICENTER SURVEY IN JAPAN

12. AB0625 Association between Cytomegalovirus Reactivation and Renal Prognosis during Remission Induction Therapy for ANCA-Associated Vasculitis

19. Quantum transport in an atom-sized bridge between a metal surface and a tip of a scanning tunneling microscope at finite temperature

30. Engineering validation for lithium target facility of the IFMIF under IFMIF/EVEDA project

34. AB0247 A New Disease Activity Biomarker Alternative To CRP under Tocilizumab Therapy for Rheumatoid Arthritis via Peptidomic Analysis

35. AB0256 Very Early Response To Abatacept Could Be A Predictive Factor for Repair of Bone Erosion in Patients with Rheumatoid Arthritis Assessed by MRI

37. AB0910 Once-Weekly Teriparatide is Effective for Glucocorticoid-Induced Osteoporosis Patients with Collagen Diseases

38. AB0472 Predicting Factors Associated with Sustained Clinical Remission by Abatacept are Different Between in Younger and Elderly Patients with Biologic-Naïve Rheumatoid Arthritis (Abroad Study)

39. Engineering Validation and Engineering Design of Lithium Target Facility in IFMIF/EVEDA Project

40. AB0439 T Cell CD80/Cd86 Co-Stimulatory Blockade Does not Suppress CD8 (+) Subpopulation in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis

42. OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, is A Novel Therapeutic Target of Rheumatoid Arthritis

43. AB0501 Retrospective Study of Multitarget Therapy with Combination of Mizoribine and Tacrolimus for Systemic Lupus Erythematosus with or without Nephritis

44. SAT0239 T Cell CD80/Cd86 Co-Stimulatory Blockade Effectively Suppresses CD25 (+) in CD4 (+) T Cell Subpopulation but not the ACPA Titers in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis

46. SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients

47. SAT0121 Changes in Cytokine Profiles in Rheumatoid Arthritis Patients During Abatacept Treatment

48. FRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis

Catalog

Books, media, physical & digital resources